Zingiber officinale Roscoe on reducing ischemia-reperfusion injury

The effect of Zingiber officinale Roscoe on reducing ischemia-reperfusion injury in patients undergoing coronary angioplasty

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180118038426N1

Enrollment

Registered

2018-03-04

Start date

2018-02-25

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease. 120-125

Interventions

Intervention 1: Intervention group: In the intervention group, Zinatuma capsule 250 mg is prescribed once a day for 10 days. Intervention 2: Control group: This group is prescribed a placebo capsule f

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: Having a stenosis of at least 70% in at least one coronary artery

Exclusion criteria

Exclusion criteria: Ginger consumption 6 months before Study-Ginger sensitivity and its compounds-Chest pain 48 hours before Angioplasty

Design outcomes

Primary

Measure	Time frame
Troponin enzyme. Timepoint: 24 hours after angioplasty. Method of measurement: labratory kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactafshin nazari

Khoram-Abad University of Medical Sciences

nazary257@gmail.com+98 66 3312 0133

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026